Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. announced that the FDA has approved Sezaby (phenobarbital sodium powder for injection) for the treatment of neonatal seizures.
The FDA has approved Spritam (levetiracetam), from Aprecia Pharmaceuticals, for oral use as a prescription adjunctive therapy in the treatment...